scholarly journals Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial

2013 ◽  
Vol 17 (4) ◽  
pp. 711-717 ◽  
Author(s):  
Gianluca Tomasello ◽  
Wanda Liguigli ◽  
Rossana Poli ◽  
Silvia Lazzarelli ◽  
Matteo Brighenti ◽  
...  
1988 ◽  
Vol 74 (3) ◽  
pp. 313-315 ◽  
Author(s):  
Eduardo Cazap ◽  
Roberto Estevez ◽  
Mario Bruno ◽  
Daniel Levy ◽  
Carlos Algamiz ◽  
...  

Patients with locally advanced or metastatic gastric adenocarcinoma received an i.v. bolus of 4′-epi-doxorubicin, 75/mg/m2/cycle, every 21 days. Partial responses were observed in 5 of 23 evaluable patients (21.7%). Treatment was generally well tolerated and toxicity was mild. The response rate to epirubicin appears to be very similar to that reported for doxorubicin. Larger doses of epirubicin could be safely used in future studies, and further evaluation of epirubicin in phase III trials is indicated.


1991 ◽  
Vol 14 (4) ◽  
pp. 357-358 ◽  
Author(s):  
Artur Katz ◽  
Rene C. Gansl ◽  
Sergio D. Simon ◽  
Joaquim Gama-Rodrigues ◽  
Dan Waitzberg ◽  
...  

2019 ◽  
Vol 112 ◽  
pp. 20-28
Author(s):  
Chan Kim ◽  
Hong Jae Chon ◽  
Joo Hoon Kim ◽  
Minkyu Jung ◽  
Chung Mo Nam ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document